BACKGROUNDRadiotherapy alone was long the standard nonsurgical therapy for locally advanced disease. A recent meta-analysis of randomised trial testing modified fractionation schemes against conventional once-daily fractionation demonstrated that hyperfractionation was the most effective strategy, leading to an 8% absolute improvement in 5-year survival. Split-course technique has been used in head and neck cancer patients as an alternative to conventional fractionation. Current evidence shows that split-course radiotherapy is radiobiologically sound and produces similar results as conventional radiotherapy with less number of fractions and increased patient compliance. In our study, we would like to present the results of split-course radiotherapy in advanced head and neck cancer. Aims and Objectives-To evaluate split-course accelerated hyperfractionated radiotherapy in aspects of Local Tumour Control and early and Late Radiation Toxicity.